DMD and Duchenne muscular dystrophy: Future molecular analysis of RFs will also provide invaluable information toward the development of molecular therapies, such as antisense-mediated exon skipping, which are aimed at inducing the production of revertant-like dystrophin-positive fibers for the treatment of DMD [8], [66], [67].